COMPARISON OF ACETYLATION OF PROCAINAMIDE AND SULFADIMIDINE IN MAN

被引：29

作者：

FRISLID, K

BERG, M

HANSTEEN, V

LUNDE, PKM

机构：

[1] ULLEVAL HOSP,CENT LAB,DIV CLIN PHARMACOL & TOXICOL,OSLO 1,NORWAY

[2] ULLEVAL HOSP,DEPT MED 8,OSLO,NORWAY

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1976年 / 9卷 / 5-6期

关键词：

D O I：

10.1007/BF00606561

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：433 / 438

页数：6

共 18 条

[1]

ATKINSON AJ, 1972, CLIN CHEM, V18, P643

[2]

DRAYER DE, 1974, P SOC EXP BIOL MED, V146, P358

[3]

DREYFUSS J, 1972, CLIN PHARMACOL THER, V13, P366

[4] ANTIARRHYTHMIC POTENCY OF N-ACETYLPROCAINAMIDE [J].

ELSON, J ;

STRONG, JM ;

LEE, WK ;

ATKINSON, AJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) :134-140

[5]

EVANS D A P, 1969, Journal of Medical Genetics, V6, P405, DOI 10.1136/jmg.6.4.405

[6] NEW SUSTAINED-RELEASE TABLET FORMULATION OF PROCAINAMIDE [J].

FREMSTAD, D ;

DAHL, S ;

JACOBSEN, S ;

LUNDE, PKM ;

NADLAND, KJ ;

MARTHINSEN, AA ;

WAALER, T ;

LANDMARK, KH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (04) :251-255

[7]

FRISLID K, 1975, CLIN CHEM, V21, P1180

[8]

GIBSON TP, 1975, CLIN PHARMACOL THER, V17, P395

[9]

GIBSON TP, 1975, CLIN PHARMACOL THER, V17, P321

[10]

GRAFFNER C, 1975, CLIN PHARMACOL THER, V17, P414

← 1 2 →